Business Description
BioArctic AB
ISIN : SE0010323311
Share Class Description:
OSTO:BIOA B: Class BCompare
Compare
Traded in other countries / regions
BIOA B.Sweden0RV2.UKBRCTF.USAB9A.Germany IPO Date
2017-10-12Description
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 223.25 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 783.42 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 73 | |||||
| Beneish M-Score | 14.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 114.3 | |||||
| 3-Year Book Growth Rate | 4.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.05 | |||||
| 9-Day RSI | 47.24 | |||||
| 14-Day RSI | 45.18 | |||||
| 6-1 Month Momentum % | -5.76 | |||||
| 12-1 Month Momentum % | -6.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.22 | |||||
| Quick Ratio | 9.22 | |||||
| Cash Ratio | 8.89 | |||||
| Days Sales Outstanding | 0.13 | |||||
| Days Payable | 104.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 0.04 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 85.45 | |||||
| Operating Margin % | 41.72 | |||||
| Net Margin % | 37.22 | |||||
| FCF Margin % | 50.28 | |||||
| ROE % | 22.74 | |||||
| ROA % | 20.73 | |||||
| ROIC % | 112 | |||||
| ROC (Joel Greenblatt) % | 240.5 | |||||
| ROCE % | 26.57 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 74.72 | |||||
| Forward PE Ratio | 196.08 | |||||
| PE Ratio without NRI | 74.72 | |||||
| Price-to-Owner-Earnings | 67.57 | |||||
| PS Ratio | 27.89 | |||||
| PB Ratio | 16.33 | |||||
| Price-to-Tangible-Book | 16.67 | |||||
| Price-to-Free-Cash-Flow | 55.61 | |||||
| Price-to-Operating-Cash-Flow | 55.61 | |||||
| EV-to-EBIT | 60.76 | |||||
| EV-to-Forward-EBIT | 206.02 | |||||
| EV-to-EBITDA | 56.86 | |||||
| EV-to-Forward-EBITDA | 165.36 | |||||
| EV-to-Revenue | 26.51 | |||||
| EV-to-Forward-Revenue | 28.55 | |||||
| EV-to-FCF | 49.07 | |||||
| Price-to-Projected-FCF | 17.01 | |||||
| Price-to-Graham-Number | 7.52 | |||||
| Price-to-Net-Current-Asset-Value | 17.22 | |||||
| Price-to-Net-Cash | 17.94 | |||||
| Earnings Yield (Greenblatt) % | 1.65 | |||||
| FCF Yield % | 1.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioArctic AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 615.995 | ||
| EPS (TTM) (kr) | 2.59 | ||
| Beta | 0 | ||
| Volatility % | 42.48 | ||
| 14-Day RSI | 45.18 | ||
| 14-Day ATR (kr) | 11.399033 | ||
| 20-Day SMA (kr) | 201.23 | ||
| 12-1 Month Momentum % | -6.32 | ||
| 52-Week Range (kr) | 175 - 392 | ||
| Shares Outstanding (Mil) | 88.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioArctic AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioArctic AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioArctic AB Frequently Asked Questions
What is BioArctic AB(OSTO:BIOA B)'s stock price today?
The current price of OSTO:BIOA B is kr197.50. The 52 week high of OSTO:BIOA B is kr392.00 and 52 week low is kr175.00.
When is next earnings date of BioArctic AB(OSTO:BIOA B)?
The next earnings date of BioArctic AB(OSTO:BIOA B) is 2024-05-17.
Does BioArctic AB(OSTO:BIOA B) pay dividends? If so, how much?
BioArctic AB(OSTO:BIOA B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers